29 stocks received institutional buy ratings today, and 4 stocks were paid attention to by institutions for the first time.

According to the statistics of Securities Times and Databao, a total of 41 buy rating records were issued in today's institutional research reports, involving a total of 29 stocks. Yanjing Beer has received the most attention, with a total of 8 institutional buy ratings.

A total of 18 of the stocks with institutional buy ratings today have given future price targets to the relevant stocks. On January 16, Huatai Securities expects the company's target price to be 58.71 yuan, with an upside of 43.20%, and stocks with higher upside are Sun Paper, Wasion Information, etc., with an upside of 29.50% and 29.24% respectively.

From the perspective of institutional rating changes, among today's institutional buy rating records, there are 4 rating records that institutions pay attention to for the first time, involving 4 stocks such as Canqin Technology and Huafeng Technology.

In terms of market performance, stocks with institutional buy ratings rose an average of 1.86% today, outperforming the Shanghai Composite Index. There are 22 stock prices that have risen, and there are Jinhong Group and so on. The top gainers are Renfu Pharmaceutical, Jinkong Coal, Huafeng Technology, etc., which rose by 7.79%, 7.35%, and 5.30% respectively today. Stocks with large declines include Shentong Express, Dinglong Shares, Jingye Intelligence, etc., with declines of 1.19%, 1.16%, and 0.91% respectively.

In terms of performance, among the stocks rated by institutions to buy, 3 shares have announced their annual performance reports, and the net profit growth rate is higher Jinhong Group, China Merchants Bank, and Industrial Bank, with an increase of 3.02%, 1.22%, and 0.12% respectively. A total of 12 announced the annual performance forecast, in terms of the median net profit growth, the highest net profit increase is Shentong Express, the company is expected to increase the annual performance net profit by 193.52% year-on-year, followed by Dinglong shares, Arcsoft Technology, etc., the median net profit growth rate is expected to be 129.72% and 101.16% respectively.

From the perspective of the industry, the pharmaceutical and biological industry is the most favored, and 5 stocks such as Humanwell Pharmaceutical and Yunnan Baiyao are on the list of institutional buy ratings. Electronics, communications and other industries are also more concerned by institutions, with 3 and 2 stocks on the list respectively. (Data Treasure).

Institutional buy rating record today